Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Beclobrate (Sgd 24774) is a novel orally available fibric acid derivative that has shown significant lipid and cholesterol-lowering activity in rodents and may be used in the study of primary hyperlipoproteinemia.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 67,500 |
5 mg | 在庫あり | ¥ 166,000 |
10 mg | 在庫あり | ¥ 226,500 |
25 mg | 在庫あり | ¥ 349,000 |
50 mg | 在庫あり | ¥ 454,500 |
100 mg | 在庫あり | ¥ 574,000 |
説明 | Beclobrate (Sgd 24774) is a novel orally available fibric acid derivative that has shown significant lipid and cholesterol-lowering activity in rodents and may be used in the study of primary hyperlipoproteinemia. |
In vivo | On a normal diet, beclobrate lowered total plasma cholesterol levels by 22-33.4% (10-50 mg/kg), the reduction in cholesterol occurred mainly in high-density lipoproteins (HDL), with a decrease of 24-45% at the three tested doses[1]. |
別名 | Sgd 24774 |
分子量 | 346.85 |
分子式 | C20H23ClO3 |
CAS No. | 55937-99-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Beclobrate 55937-99-0 Others Sgd 24774 Inhibitor inhibitor inhibit